Pesquisar
Akoustis Technologies Ord Shs
AKTSAdicionar à lista de desejos
27.050USD
+0.400+1.50%
Fechamento 09-04 16:00（ET）
1.50BValor de mercado
PerdaP/L TTM
Mais detalhes de Akoustis Technologies Ord Shs Empresa
Aktis Oncology Inc is a United States-based biotechnology company. The Company focuses on developing targeted radiopharmaceuticals for treating solid tumor cancers. It also aims to deliver high doses of radiation directly to tumors, minimizing harm to healthy tissue. It transforms cancer care with novel platform technologies that enables to design and develop precision for radiopharmaceuticals. Its drugs are designed to bind to specific proteins on cancer cells, delivering radiation directly to the tumor.
Akoustis Technologies Ord Shs Perfil
Código da empresaAKTS
Nome da EmpresaAktis Oncology Inc
Data de listagemJan 09, 2026
CEORoden (Matthew)
Número de funcionários117
Tipo de títulosOrdinary Share
Fim do ano fiscalJan 09
Endereço17 Drydock Avenue
CidadeBOSTON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal02210
Telefone13026587581
Sitehttps://www.aktisoncology.com/
Código da empresaAKTS
Data de listagemJan 09, 2026
CEORoden (Matthew)
Executivos da empresa Akoustis Technologies Ord Shs
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Matthew (Matt) Roden, Ph.D.
Mr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Mr. Matthew (Matt) Roden, Ph.D.
Mr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Mr. Matthew (Matt) Roden, Ph.D.
Mr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Mr. Paul L. Feldman, Ph.D.
Mr. Paul L. Feldman, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Tyler Benedum, Ph.D.
Mr. Tyler Benedum, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Mr. Todd Foley
Mr. Todd Foley
Chairman of the Board
Chairman of the Board
--
-100.00%
Ms. Shulamit Ron-Bigger, Ph.D.
Ms. Shulamit Ron-Bigger, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Kyle D. Kuvalanka
Mr. Kyle D. Kuvalanka
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Akos Czibere, M.D.
Mr. Akos Czibere, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Ken Herrmann, M.D.
Mr. Ken Herrmann, M.D.
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Matthew (Matt) Roden, Ph.D.
Mr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Mr. Matthew (Matt) Roden, Ph.D.
Mr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Mr. Matthew (Matt) Roden, Ph.D.
Mr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Mr. Paul L. Feldman, Ph.D.
Mr. Paul L. Feldman, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Tyler Benedum, Ph.D.
Mr. Tyler Benedum, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Mr. Todd Foley
Mr. Todd Foley
Chairman of the Board
Chairman of the Board
--
-100.00%
Perguntas frequentes
Quem são os cinco principais acionistas de Akoustis Technologies Ord Shs?
Os cinco principais acionistas de Akoustis Technologies Ord Shs são: Mr. Matthew (Matt) Roden, Ph.D.
Quantas instituições possuem ações da Akoustis Technologies Ord Shs (AKTS)?
Em 2026Q1, 195 instituições possuíam ações da Akoustis Technologies Ord Shs, com valor de mercado aproximado de 27.52M, representando 51.47% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 1127277.00.